Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

1239005

USP

Ergocalciferol

United States Pharmacopeia (USP) Reference Standard

Sinonimo/i:

Calciferol, Ercalciol, Ergosterol irradiated, Irradiated ergosterol, Vitamin D2

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C28H44O
Numero CAS:
50-14-6
Peso molecolare:
396.65
Beilstein:
1916682
Numero MDL:
MFCD00166988
Codice UNSPSC:
41116107
ID PubChem:
329749739
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

ergocalciferol

Produttore/marchio commerciale

USP

Punto di fusione

114-118 °C (lit.)

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

−20°C

Stringa SMILE

CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@]1([H])CC[C@@]([C@]1(C)CCC/2)([H])C2=C\C=C(C[C@@H](O)CC3)/C3=C

InChI

1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1
MECHNRXZTMCUDQ-RKHKHRCZSA-N

Informazioni sul gene

human ... VDR(7421)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Risultati analitici

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Altre note

Sales restrictions may apply.

Pittogrammi

Skull and crossbonesHealth hazard
GHS06,GHS08

Avvertenze

Danger

Indicazioni di pericolo

H301 + H311,H330,H372

Classi di pericolo

Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral

Codice della classe di stoccaggio

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 9

1 of 9

Colecalciferolo (D3) analytical standard

Supelco

47763

Colecalciferolo (D3)

Colecalciferolo European Pharmacopoeia (EP) Reference Standard

C2100000

Colecalciferolo

Colecalciferolo analytical standard

Sigma-Aldrich

C9774

Colecalciferolo

Colecalciferolo ≥98% (HPLC)

Sigma-Aldrich

C9756

Colecalciferolo

Retinyl palmitate United States Pharmacopeia (USP) Reference Standard

USP

1602502

Retinyl palmitate

α-Tocopherol acetate European Pharmacopoeia (EP) Reference Standard

T1600000

α-Tocopherol acetate

Parabeni metilici United States Pharmacopeia (USP) Reference Standard

USP

1432005

Parabeni metilici

DL-alpha-Tocopherol acetate analytical standard

Supelco

47786

DL-alpha-Tocopherol acetate

(±)-α-tocoferolo Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1031

(±)-α-tocoferolo

Gavin Dreyer et al.
PloS one, 9(7), e99461-e99461 (2014-07-10)
Vitamin D deficiency and endothelial dysfunction are non-traditional risk factors for cardiovascular events in chronic kidney disease. Previous studies in chronic kidney disease have failed to demonstrate a beneficial effect of vitamin D on arterial stiffness, left ventricular mass and
Tom D Thacher et al.
Archives of disease in childhood, 99(9), 807-811 (2014-04-22)
To determine whether children with calcium-deficiency rickets have a better response to treatment with vitamin D and calcium than with calcium alone. Randomised controlled trial. Jos University Teaching Hospital, Jos, Nigeria. Nigerian children with active rickets treated with calcium carbonate
Daniela Max et al.
Molecular nutrition & food research, 58(2), 343-352 (2013-08-22)
Epidemiologic data reveal associations between low serum concentrations of 25-hydroxyvitamin D (25(OH)D) and higher risk of falls and muscle weakness. Fetal stage is critical for the development of skeletal muscle, but little information is available on the impact of maternal
James E Heubi et al.
Hepatology (Baltimore, Md.), 61(1), 268-274 (2014-08-29)
Bile acid amidation defects were predicted to present with fat/fat soluble vitamin malabsorption with minimal cholestasis. We identified and treated five patients (one male, four females) from four families with defective bile acid amidation due to a genetically confirmed deficiency
Wei-Jie Wu et al.
PloS one, 9(4), e95359-e95359 (2014-04-17)
Response surface methodology (RSM) was used to determine the optimum vitamin D2 synthesis conditions in oyster mushrooms (Pleurotus ostreatus). Ultraviolet B (UV-B) was selected as the most efficient irradiation source for the preliminary experiment, in addition to the levels of
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.